Simultaneous gas-chromatographic urinary measurement of sugar probes to assess intestinal permeability: Use of time course analysis to optimize its use to assess regional gut permeability

Clinica Chimica Acta

Volumn 442, Issue , 2015, Pages 24-32

  Shaikh, Maliha ^a   Rajan, Kumar ^b   Forsyth, Christopher B ^a,c   Voigt, Robin M ^a   Keshavarzian, Ali ^a,c,d,e  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY   (United States)

^d RUSH MEDICAL COLLEGE   (United States)

^e UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Intestinal permeability; Lactulose; Leaky gut; Mannitol; Sucralose; Urine

Indexed keywords

LACTULOSE; MANNITOL; SUCRALOSE; SUCROSE; CARBOHYDRATE;

ACCURACY; ADULT; AGE; ANALYTICAL PARAMETERS; ARTICLE; BODY MASS; CARBOHYDRATE ANALYSIS; CHEMICAL REACTION KINETICS; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; GAS CHROMATOGRAPH; GAS CHROMATOGRAPHY; GASTROINTESTINAL ABSORPTION; GENDER; HUMAN; INTESTINE MUCOSA PERMEABILITY; KIDNEY FUNCTION; LACTULOSE TO MANNITOL RATIO; LARGE INTESTINE; MALE; MIDDLE AGED; PARKINSON DISEASE; RACE; REPRODUCIBILITY; SMALL INTESTINE; SMOKING; SUCRALOSE TO LACTULOSE RATIO; TIME; URINALYSIS; URINARY EXCRETION; URINE LEVEL; AGED; AGING; CARBOHYDRATE METABOLISM; INTESTINE; INTESTINE ABSORPTION; KIDNEY FUNCTION TEST; KINETICS; METABOLISM; NORMAL HUMAN; PERMEABILITY; PROCEDURES; SEXUAL DEVELOPMENT; URINE; YOUNG ADULT;

ADULT; AGED; AGING; BODY MASS INDEX; CARBOHYDRATE METABOLISM; CARBOHYDRATES; CHROMATOGRAPHY, GAS; FEMALE; HEALTHY VOLUNTEERS; HUMANS; INTESTINAL ABSORPTION; INTESTINES; KIDNEY FUNCTION TESTS; KINETICS; MALE; MIDDLE AGED; PERMEABILITY; SEX CHARACTERISTICS; SMOKING; TIME FACTORS; URINALYSIS; YOUNG ADULT;

EID: 84921314730     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.12.040     Document Type: Article

References (41)

1. Frazier T.H., DiBaise J.K., McClain C.J. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. JPEN J Parenter Enteral Nutr 2011, 35:14S-20S.
2. Bested A.C., Logan A.C., Selhub E.M. Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part II - contemporary contextual research. Gut Pathog 2013, 5:3.
3. Heberling C.A., Dhurjati P.S., Sasser M. Hypothesis for a systems connectivity model of Autism Spectrum Disorder pathogenesis: links to gut bacteria, oxidative stress, and intestinal permeability. Med Hypotheses 2013, 80:264-270.
4. Moreira A.P., Texeira T.F., Ferreira A.B., Peluzio Mdo C., Alfenas Rde C. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 2012, 108:801-809.
5. Turner J.R. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009, 9:799-809.
6. Clayburgh D.R., Shen L., Turner J.R. A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest 2004, 84:282-291.
7. Farhadi A., Banan A., Fields J., Keshavarzian A. Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol 2003, 18:479-497.
8. Shen L., Weber C.R., Raleigh D.R., Yu D., Turner J.R. Tight junction pore and leak pathways: a dynamic duo. Annu Rev Physiol 2011, 73:283-309.
9. Arrieta M.C., Bistritz L., Meddings J.B. Alterations in intestinal permeability. Gut 2006, 55:1512-1520.
10. Salim S.Y., Soderholm J.D. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis 2011, 17:362-381.
11. Camilleri M., Madsen K., Spiller R., Greenwood-Van Meerveld B., Verne G.N. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil 2012, 24:503-512.
12. Heyman M., Abed J., Lebreton C., Cerf-Bensussan N. Intestinal permeability in coeliac disease: insight into mechanisms and relevance to pathogenesis. Gut 2012, 61:1355-1364.
13. Grivennikov S.I., Wang K., Mucida D., Stewart C.A., Schnabl B., Jauch D., et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012, 491:254-258.
14. Ilan Y. Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis. World J Gastroenterol 2012, 18:2609-2618.
15. Szabo G., Bala S. Alcoholic liver disease and the gut-liver axis. World J Gastroenterol 2010, 16:1321-1329.
16. Cani P.D., Osto M., Geurts L., Everard A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 2012, 3:279-288.
17. Delzenne N.M., Cani P.D. Gut microbiota and the pathogenesis of insulin resistance. Curr Diab Rep 2011, 11:154-159.
18. Forsyth C.B., Shannon K.M., Kordower J.H., Voigt R.M., Shaikh M., Jaglin J.A., et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS One 2011, 6:e28032.
19. Mayer E.A., Collins S.M. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 2002, 122:2032-2048.
20. Maes M., Kubera M., Leunis J.C. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett 2008, 29:117-124.
21. Bjarnason I., MacPherson A., Hollander D. Intestinal permeability: an overview. Gastroenterology 1995, 108:1566-1581.
22. Hollander D., Vadheim C.M., Brettholz E., Petersen G.M., Delahunty T., Rotter J.I. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med 1986, 105:883-885.
23. Rao A.S., Camilleri M., Eckert D.J., Busciglio I., Burton D.D., Ryks M., et al. Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls. Am J Physiol Gastrointest Liver Physiol 2011, 301:G919-G928.
24. Farhadi A., Keshavarzian A., Fields J.Z., Sheikh M., Banan A. Resolution of common dietary sugars from probe sugars for test of intestinal permeability using capillary column gas chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2006, 836:63-68.
25. Lotfipour S., Howard J., Roumani S., Hoonpongsimanont W., Chakravarthy B., Anderson C.L., et al. Increased detection of alcohol consumption and at-risk drinking with computerized alcohol screening. J Emerg Med 2013, 44:861-866.
26. Abazia C., Ferrara R., Corsaro M.M., Barone G., Coccoli P., Parrilli G. Simultaneous gas-chromatographic measurement of rhamnose, lactulose and sucrose and their application in the testing gastrointestinal permeability. Clin Chim Acta 2003, 338:25-32.
27. Monson T.P., Wilkinson K.P. d-Mannose in human serum, measured as its aldononitrile acetate derivative. Clin Chem 1979, 25:1384-1387.
28. Lees A.J., Hardy J., Revesz T. Parkinson's disease. Lancet 2009, 373:2055-2066.
29. Dorsey E.R., Constantinescu R., Thompson J.P., Biglan K.M., Holloway R.G., Kieburtz K., et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007, 68:384-386.
30. Meddings J.B., Gibbons I. Discrimination of site-specific alterations in gastrointestinal permeability in the rat. Gastroenterology 1998, 114:83-92.
31. Kararli T.T. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos 1995, 16:351-380.
32. Daugherty A.L., Mrsny R.J. Transcellular uptake mechanisms of the intestinal epithelial barrier Part one. Pharm Sci Technol Today 1999, 4:144-151.
33. Rouge N., Buri P., Doelker E. Drug absorption sites in the gastrointestinal tract and dosage forms for site specific delivery. Int J Pharm 1996, 136:117-139.
34. John B.A., Wood S.G., Hawkins D.R. The pharmacokinetics and metabolism of sucralose in the rabbit. Food Chem Toxicol 2000, 38(Suppl. 2):S111-S113.
35. John B.A., Wood S.G., Hawkins D.R. The pharmacokinetics and metabolism of sucralose in the mouse. Food Chem Toxicol 2000, 38(Suppl. 2):S107-S110.
36. Roberts A., Renwick A.G., Sims J., Snodin D.J. Sucralose metabolism and pharmacokinetics in man. Food Chem Toxicol 2000, 38(Suppl. 2):S31-S41.
37. Wood S.G., John B.A., Hawkins D.R. The pharmacokinetics and metabolism of sucralose in the dog. Food Chem Toxicol 2000, 38(Suppl. 2):S99-S106.
38. Sims J., Roberts A., Daniel J.W., Renwick A.G. The metabolic fate of sucralose in rats. Food Chem Toxicol 2000, 38(Suppl. 2):S115-S121.
39. Farhadi A., Keshavarzian A., Holmes E.W., Fields J., Zhang L., Banan A. Gas chromatographic method for detection of urinary sucralose: application to the assessment of intestinal permeability. J Chromatogr B Analyt Technol Biomed Life Sci 2003, 784:145-154.
40. McOmber M.E., Ou C.N., Shulman R.J. Effects of timing, sex, and age on site-specific gastrointestinal permeability testing in children and adults. J Pediatr Gastroenterol Nutr 2010, 50:269-275.
41. Del Valle-Pinero A.Y., Van Deventer H.E., Fourie N.H., Martino A.C., Patel N.S., Remaley A.T., et al. Gastrointestinal permeability in patients with irritable bowel syndrome assessed using a four probe permeability solution. Clin Chim Acta 2013, 418:97-101.